YUKEN NSE filing

Yuken India Appoints Yoshitake Tanaka as Whole-time Director for 4 Years

The RealCase readMedium impact Positive

Yuken India's Board approved changing Mr. Yoshitake Tanaka's designation to Whole-time Director for four years, effective October 1, 2026. This change requires shareholder approval. Mr. Tanaka has extensive experience and has been with the company since August 2022.

Why it matters

The change in designation of a key management personnel to a Whole-time Director role for a significant tenure is a material event that can impact the company's strategic direction and operational execution.

The market read

The appointment of a Whole-time Director with extensive experience is generally viewed positively as it indicates a strengthening of management and operational oversight.

Yuken India Limited announced that its Board of Directors, following a recommendation from the Nomination and Remuneration Committee, has approved the change in designation of Mr. Yoshitake Tanaka. He will now serve as a Whole-time Director for a period of four years, effective from October 1, 2026.

This appointment is subject to the approval of the company's shareholders at the upcoming General Meeting. The Board meeting where this decision was made commenced at 12:10 PM IST and concluded at 3:40 PM IST on August 11, 2026.

Mr. Tanaka is not related to any other Directors or Key Managerial Personnel of Yuken India Limited and is not debarred from holding a Director's office by any authority. He holds a graduate degree in Business Administration from Senshu University, Japan, and possesses extensive experience in supply chain management, procurement, production control, corporate governance, and cross-functional business operations. He has been associated with the company since August 2022, previously serving as a Whole-time Director from September 14, 2022, to September 19, 2024, and subsequently as a Non-Executive Director.

Filing to action

What to do with a filing like this

Yuken India Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Yuken India Limited. Read the original for the full detail.

View original filing